These activities, as well as the in vivo tumor- and metastasis-promoting effects of PD-L1 in a T cell-independent system, demonstrated that PD-L1 acts in a cell-autonomous manner to increase aggressiveness in breast cancer. Here, CD274 is linked to breast carcinoma.